English

Choose language

PeptiKingREVIEW

Blog

Hexarelin: looking beyond a single hormone response

The paper tests mechanism while observing more than one signal. Readers should evaluate the complete response rather than selecting the most marketable hormone change.

PeptiKing Review · Blog

Evidence discussed: Small randomized human physiology study.

What the researchers studied

A double-blind randomized experiment in 12 healthy volunteers investigated hexarelin, an opioid antagonist and placebo. Hexarelin stimulated growth hormone and also increased prolactin, cortisol and ACTH under the tested conditions. [1]

How to interpret the result

The study did not measure muscle growth, sports recovery or long-term health. Its multiple endocrine effects limit descriptions focused only on growth hormone. A short experiment cannot define consequences of repeated exposure.

What readers can take from it

The paper tests mechanism while observing more than one signal. Readers should evaluate the complete response rather than selecting the most marketable hormone change.

This original editorial summary provides no diagnosis, dosing or treatment advice. The study did not test or certify a PeptiKing product.

Source

[1] Hexarelin hormonal responses in volunteers (1995). PMID: 7586608. Based on the PubMed-indexed abstract and record; full-text methods were not independently reviewed.

Back to the blog
Hexarelin: looking beyond a single hormone response | PeptiKing Review